Cargando…
COVID 19 Associated Mucormycosis: Preventable Risk Factors Leading to a Better Prognosis: A Case Series
India was severely affected by the second wave of coronavirus disease (COVID‑19), leading to sudden expansive spread of Mucormycosis, presenting with sinusitis, blackish mucus secretions, discolouration of palate, facial pain, swelling and blurring of vision. Hyperglycemia, hypercoagulable state and...
Autores principales: | Nayak, Puneeth S., Katyal, Isha, Kumar, Adarsh D., Prasheetha, B., Harugop, Anil S., Reshma, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486771/ https://www.ncbi.nlm.nih.gov/pubmed/36160947 http://dx.doi.org/10.1007/s12070-022-03163-5 |
Ejemplares similares
-
Quality of Life in Mucormycosis Patients Post Discharge: A Pilot Study Using a New MQOL-36 Questionairre
por: Nayak, Puneeth S., et al.
Publicado: (2022) -
Recurrent mucormycosis – Better understanding of treatment and management
por: Panneerselvam, Karthika, et al.
Publicado: (2020) -
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Qu, Junyan, et al.
Publicado: (2021) -
Mucormycosis: A Case Series
por: Yong, Jo Yen, et al.
Publicado: (2023) -
Pulmonary tuberculosis and mucormycosis co-infection in a diabetic patient
por: Aggarwal, Deepak, et al.
Publicado: (2015)